VHC VirnetX Holding Corp
Patent Owners & Lessors · Nasdaq · SEC CIK 1082324 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
Margins
Returns
Leverage & solvency
Cash quality & payout
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $0 | $0 | $0 | $56,000 | $58,000 | $48,000 | $0 | $0 |
| R&D expense | $972,000 | $1.13M | $1.16M | $2.04M | $1.14M | $1.22M | $1.26M | $2.37M |
| SG&A expense | $3.63M | $3.53M | $3.35M | $4.82M | $3.06M | $2.78M | $2.79M | $4.30M |
| Operating income | -$4.61M | -$4.65M | -$4.51M | -$6.80M | -$4.64M | -$3.94M | -$4.05M | -$6.67M |
| Pretax income | -$4.51M | -$4.53M | -$4.35M | -$6.58M | -$4.35M | -$3.62M | -$3.68M | -$6.21M |
| Income tax | $0 | $0 | $0 | -$4,000 | $0 | $0 | $2,000 | $0 |
| Net income | -$4.51M | -$4.53M | -$4.35M | -$6.58M | -$4.35M | -$3.62M | -$3.68M | -$6.21M |
| EBITDA | -$4.60M | -$4.64M | -$4.50M | -$6.80M | -$4.64M | -$3.94M | -$4.04M | -$6.66M |
| EPS (basic) | -1.19 | -1.20 | -1.16 | — | -1.18 | -0.99 | -1.01 | — |
| EPS (diluted) | -1.19 | -1.20 | -1.16 | — | -1.18 | -0.99 | -1.01 | — |
| Dividends declared per share | — | — | — | — | — | — | — | 0.00 |
| Weighted avg. shares (diluted) | 3.81M | 3.77M | 3.75M | — | 3.67M | 3.66M | 3.63M | — |
| Balance sheet | ||||||||
| Cash & equivalents | $10.05M | $13.09M | $14.77M | $15.55M | $17.13M | $17.29M | $23.22M | $23.30M |
| Short-term investments | $499,000 | $799,000 | $2.45M | $5.98M | $11.06M | $13.93M | $10.95M | $14.79M |
| Receivables | $0 | $0 | $0 | $19,000 | $19,000 | $48,000 | — | $0 |
| Current assets | $10.67M | $14.11M | $17.56M | $21.67M | $28.43M | $31.54M | $34.58M | $38.20M |
| PP&E, net | $49,000 | $56,000 | $55,000 | $61,000 | $68,000 | $57,000 | $62,000 | $67,000 |
| Total assets | $19.27M | $22.97M | $26.69M | $31.06M | $37.98M | $41.82M | $45.11M | $49.61M |
| Current liabilities | $2.44M | $2.26M | $2.06M | $2.02M | $2.07M | $1.94M | $1.95M | $7.20M |
| Total liabilities | $7.96M | $7.91M | $7.84M | $8.59M | $8.69M | $8.65M | $8.75M | $9.99M |
| Shareholders' equity | $11.30M | $15.06M | $18.85M | $22.47M | $29.29M | $33.17M | $36.36M | $39.62M |
| Shares outstanding | 4.20M | 4.22M | 4.19M | 4.20M | 4.27M | 4.27M | 4.24M | 4.24M |
| Cash flow statement | ||||||||
| Operating cash flow | -$3.33M | -$3.32M | -$4.30M | -$5.81M | -$3.00M | -$2.94M | -$3.89M | -$5.51M |
| Capital expenditure | $0 | — | — | $0 | $17,000 | — | — | $11,000 |
| Free cash flow | -$3.33M | — | — | -$5.81M | -$3.02M | — | — | -$5.52M |
| Investing cash flow | $301,000 | $1.64M | $3.52M | $5.08M | $2.85M | -$2.98M | $3.82M | $3.80M |
| Financing cash flow | -$9,000 | -$5,000 | -$1,000 | -$854,000 | -$12,000 | -$7,000 | $0 | -$120,000 |
| Depreciation & amortization | $7,000 | $7,000 | $6,000 | $7,000 | $6,000 | $5,000 | $5,000 | $5,000 |
| Stock-based compensation | $762,000 | $743,000 | $739,000 | $618,000 | $480,000 | $441,000 | $431,000 | $497,000 |
| Dividends paid | — | — | — | — | — | — | — | $0 |
Free plan shows the latest 8 periods; Pro shows all 71 🔒
· Financial companies (banks, insurers, …) usually do not report gross profit or operating income; bank revenue is net revenue (net interest income + noninterest income), smaller than "gross interest income + noninterest income".
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.